Johnson & Johnson
JNJ
$155.00
Share price
1.02%
Change (1 day)
-13.01%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Revenue for Johnson & Johnson (JNJ)
Revenue in 2022 (TTM): $94.94 B
According to Johnson & Johnson's latest financial reports the company's current revenue (TTM) is $94.94 B. In 2021 the company made a revenue of $93.77 B an increase over the years 2020 revenue that were of $82.58 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Johnson & Johnson from 2001 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $94.94 B | 1.25% |
| 2021 | $93.77 B | 13.55% |
| 2020 | $82.58 B | 0.64% |
| 2019 | $82.05 B | 0.59% |
| 2018 | $81.58 B | 6.71% |
| 2017 | $76.45 B | 6.34% |
| 2016 | $71.89 B | 2.59% |
| 2015 | $70.07 B | -5.73% |
| 2014 | $74.33 B | 4.23% |
| 2013 | $71.31 B | 6.08% |
| 2012 | $67.22 B | 3.37% |
| 2011 | $65.03 B | 5.59% |
| 2010 | $61.58 B | -0.5% |
| 2009 | $61.89 B | -2.9% |
| 2008 | $63.74 B | 4.34% |
| 2007 | $61.09 B | 14.57% |
| 2006 | $53.32 B | 5.56% |
| 2005 | $50.51 B | 6.69% |
| 2004 | $47.34 B | 13.1% |
| 2003 | $41.86 B | 15.33% |
| 2002 | $36.29 B | 10.75% |
| 2001 | $32.77 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $51.82 B | -45.41% | 🇨🇭 Switzerland |
 Pfizer PFE | $100.33 B | 5.67% | 🇺🇸 USA |
 Abbott Laboratories ABT | $43.65 B | -54.02% | 🇺🇸 USA |
 Medtronic MDT | $30.77 B | -67.59% | 🇮🇪 Ireland |
 Eli Lilly LLY | $28.54 B | -69.94% | 🇺🇸 USA |
 Sanofi SNY | $47.62 B | -49.84% | 🇫🇷 France |
 Gilead Sciences GILD | $27.28 B | -71.27% | 🇺🇸 USA |
 Stryker Corporation SYK | $18.44 B | -80.57% | 🇺🇸 USA |
 Merck MRK | $59.28 B | -37.56% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $38.94 B | -58.99% | 🇬🇧 UK |